首页> 外文期刊>Molecular cancer research: MCR >Network Inference Analysis Identifies SETDB1 as a Key Regulator for Reverting Colorectal Cancer Cells into Differentiated Normal-Like Cells
【24h】

Network Inference Analysis Identifies SETDB1 as a Key Regulator for Reverting Colorectal Cancer Cells into Differentiated Normal-Like Cells

机译:网络推理分析将SetDB1识别为用于将结肠直肠癌细胞重新调解到分化的正常样细胞中的关键调节器

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer cells exhibit properties of cells in a less differentiated state than the adjacent normal cells in the tissue. We explored whether cancer cells can be converted to a differentiated normal-like state by restoring the gene regulatory network (GRN) of normal cells. Here, we report that colorectal cancer cells exhibit a range of developmental states from embryonic and intestinal stem-like cells to differentiated normal-like cells. To identify the transcription factors (TF) that commit stem-like colorectal cancer cells into a differentiated normal-like state, we reconstructed GRNs of normal colon mucosa and identified core TFs (CDX2, ELF3, HNF4G, PPARG, and VDR) that govern the cellular state. We further found that SET Domain Bifurcated 1 (SETDB1), a histone H3 lysine 9-specific methyltransferase, hinders the function of the identified TFs. SETDB1 depletion effectively converts stem-like colorectal cancer cells into postmitotic cells and restores normal morphology in patient-derived colorectal cancer organoids. RNA-sequencing analyses revealed that SETDB1 depletion recapitulates global gene expression profiles of normal differentiated cells by restoring the transcriptional activity of core TFs on their target genes.
机译:癌细胞在比组织中的相邻的正常细胞中表现出细胞的特性。我们探讨了是否可以通过恢复正常细胞的基因调节网络(GRN)来将癌细胞转化为分化的正正常状态。在这里,我们报告结直肠癌细胞表现出一系列从胚胎和肠道干细胞的发育状态,以分化正常样的细胞。为了鉴定将干燥的结肠直肠癌细胞赋予分化的正常状状态的转录因子(TF),我们重建了正常结肠粘膜的GRN,并确定了管理的核心TFS(CDX2,ELF3,HNF4G,PPARG和VDR)细胞状态。我们进一步发现,设定结构域分叉1(SetDB1),组蛋白H3赖氨酸9特异性甲基转移酶,阻碍了所识别的TFS的功能。 SetDB1耗竭有效地将干燥的结直肠癌细胞转化为后蛋白细胞,并在患者衍生的结肠直肠癌有机体中恢复正常形态。 RNA测序分析显示,SetDB1耗竭通过恢复核心TFS对其靶基因的转录活性来概括正常分化细胞的全球基因表达谱。

著录项

  • 来源
    《Molecular cancer research: MCR》 |2020年第1期|共12页
  • 作者单位

    Korea Adv Inst Sci &

    Technol Dept Bio &

    Brain Engn Lab Syst Biol &

    Bioinspired Engn Daejeon;

    Sungkyunkwan Univ Sch Med Samsung Med Ctr Dept Med Seoul South Korea;

    Korea Adv Inst Sci &

    Technol Dept Bio &

    Brain Engn Lab Syst Biol &

    Bioinspired Engn Daejeon;

    Korea Adv Inst Sci &

    Technol Dept Bio &

    Brain Engn Lab Syst Biol &

    Bioinspired Engn Daejeon;

    Korea Adv Inst Sci &

    Technol Dept Bio &

    Brain Engn Lab Syst Biol &

    Bioinspired Engn Daejeon;

    Sungkyunkwan Univ Sch Med Samsung Med Ctr Dept Med Seoul South Korea;

    Sungkyunkwan Univ Sch Med Samsung Med Ctr Dept Pathol Seoul South Korea;

    Korea Adv Inst Sci &

    Technol Dept Bio &

    Brain Engn Lab Syst Biol &

    Bioinspired Engn Daejeon;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号